News from the BioRegion STERN

(Stuttgart) Insilico Biotechnology AG and Three Space Lab LLC, provider of collaborative virtual reality solutions, announce their collaboration to implement a 3D virtual Digital Twin as a key building block for a modular smart biofactory.

ATR-002 mode of action inhibits SARS-CoV-2 viral propagation and prevents the cytokine storm as demonstrated in preclinical studies Atriva’s lead product candidate is the only host-targeted antiviral specifically developed to treat respiratory infections with RNA viruses, such as influenza virus and the novel SARS-CoV-2 With i...

Now is the right time to get ready for production of a vaccine against Covid-19. We can offer the ideal solution.

The document reviews current techniques and devices used for EFTR, clinical applications and Outcomes.

Mediagnost has developed a test procedure that can detect antibodies against the new SARS-CoV-2 in human blood. The Anti-SARS-CoV-2 ELISA has been CE marked since May 6, 2020.

The aim is to develop an automated interface between unstructured and structured data

Vancouver, Canada (April 22, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that further to its press release on April 20, 2020, regarding a definitive development, technology purchase and licence agreement (the “Agreement”) with 3a-Diagnostics GmbH (“3a”), XPhyto’s wholly owned...

Vancouver, Canada (April 20, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF)(“XPhyto” or the “Company”) is pleased to announce that it has signed a definitive development, technology purchase and licence agreement (the “Agreement”) with 3a-Diagnostics GmbH (“3a”) for the development and commercialization of real-time, low-cost an...

Curetis N.V. in liquidatie (the "Company") announces that the liquidators of the Company have resolved upon a liquidation distribution in advance

Peer-reviewed study evaluated performance of AI-powered bioinformatics cloud platform, ares-genetics.cloud, for NGS-based antibiotic susceptibility testing on 12 pathogenic bacterial species and 21 antibiotic drugs   NGS-based testing reache...

COVID-19 Virtual Partnering is a unique and free-to-attend virtual event taking place on 20 April – 06 May  The initiative is backed by a consortium of biotech clusters and leading trade associations in the life sciences industry and represents a practical way to accelerate partnerships to develop and deliver solutions against COVID-19 ...

Today, the European Commission has adopted a proposal to postpone by one year the date of application of the Medical Devices Regulation to allow Member States, health institutions and economic operators to prioritise the fight against the coronavirus pandemic.

CureVac AG, a clinical stage biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that Jean Stéphenne, former deputy Chairman of the Supervisory Board, has been appointed as the new Chairman with immediate effect. Jean Stéphenne has been a member of the Board since September 2015.

Following approval of shareholders, companies sign German transfer agreement Curetis GmbH and its subsidiaries Curetis USA Inc.and Ares Genetics GmbH are now wholly owned by OpGen, Inc. OpGen consideration shares to be distributed to Curetis N.V. shareholders and Curetis N.V. to be dissolved and delisted from Euronex Three Curetis N.V. Sup...